Construction and expression of sTRAIL–melittin combining enhanced anticancer activity with antibacterial activity in Escherichia coli
- 645 Downloads
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), as an anticancer protein with tumor-selective apoptotic activity, has been examined for use in clinical application. Melittin, an antibacterial peptide isolated from the bee Apis mellifera, has shown strong cytotoxicity to both tumor and normal cells. To ameliorate the cytotoxicity of melittin on cells and enhance the activity of TRAIL on cancer cells, we constructed a novel fusion protein, sTRAIL–melittin, containing a small ubiquitin-related modifier (SUMO) tag and expressed this fusion protein in Escherichia coli. Data showed that expression of the soluble fusion protein with the SUMO tag was approximately 85 % of total target protein which was much higher than that without the SUMO tag (approximately 10 %); sTRAIL–melittin was easily purified using Ni-NTA affinity chromatography and the tag was removed easily using SUMO-specific protease. To assay anticancer activity and side effects, methyl thiazolyl tetrazolium, hemolytic, and apoptosis assays were employed. Results demonstrated that sTRAIL–melittin had cytotoxic and apoptotic activity in K562 leukemia cells and HepG2 liver carcinoma cells, while it had only a minimal effect on erythrocytes and normal HEK293 cells. This indicates that the cytotoxicity of sTRAIL–melittin in normal cells was low and the anticancer activity of the fusion protein in tumor cells was significantly enhanced compared with sTRAIL (P < 0.01). Furthermore, we found that sTRAIL–melittin also showed antibacterial activity to Staphylococcus aureus due to the presence of the melittin domain. Therefore, TRAIL fused with an antibacterial peptide may be a promising novel TRAIL-based anticancer treatment strategy.
KeywordsSUMO sTRAIL Melittin Anticancer Escherichia coli
This work was financially supported by a grant of the National Natural Science Foundation of China (Grant no. 30900743), the Natural Science Foundation of Jiangsu Province of China (Grant no. BK2011368), the Natural Science Foundation of Jiangsu Higher Education Institutions of China (Grant no. 2008104TSJ0096), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).
- Bommarius B, Jenssen H, Elliott M, Kindrachuk J, Pasupuleti M, Gieren H, Jaeger KE, Hancock RE, Kalman D (2010) Cost-effective expression and purification of antimicrobial and host defense peptides in Escherichia coli. Peptides 31:1957–1965. doi: 10.1016/j.peptides.2010.08.008 CrossRefGoogle Scholar
- Casteels P, Ampe C, Jacobs F, Tempst P (1993) Functional and chemical characterization of hymenoptaecin, an antibacterial polypeptide that is infection-inducible in the honeybee (Apis mellifera). J Biol Chem 268:7044–7054Google Scholar
- Dorsey JF, Mintz A, Tian X, Dowling ML, Plastaras JP, Dicker DT, Kao GD, El-Deiry WS (2009) Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and paclitaxel have cooperative in vivo effects against glioblastoma multiforme cells. Mol Cancer Ther 8:3285–3295. doi: 10.1158/1535-7163.mct-09-0415 CrossRefGoogle Scholar
- Gasparian ME, Ostapchenko VG, Yagolovich AV, Tsygannik IN, Chernyak BV, Dolgikh DA, Kirpichnikov MP (2007) Overexpression and refolding of thioredoxin/TRAIL fusion from inclusion bodies and further purification of TRAIL after cleavage by enteropeptidase. Biotechnol Lett 29:1567–1573. doi: 10.1007/s10529-007-9446-y CrossRefGoogle Scholar
- Miran J, Mi HP, Pushpa SK, Byeong JA, Ho SS, Sang BH, Jang HK, Min JS, Jin TH (2011) Anti-cancer effect of bee venom toxin and melittin in ovarian cancer cells through induction of death receptors and inhibition of JAK2/STAT3 pathway. Toxicol Appl Pharm 258:72–81. doi: 10.1016/j.taap. 2011.10.009 Google Scholar
- Tang HY, Qin Y, Li JY, Gong XG (2011) The scavenging of superoxide radicals promotes apoptosis induced by a novel cell-permeable fusion protein, sTRAIL:FeSOD, in tumor necrosis factor-related apoptosis-inducing ligand-resistant leukemia cells. BMC Biol 9:18. doi: 10.1186/1741-7007-9-18 CrossRefGoogle Scholar
- Wang C, Chen TY, Zhang N, Yang MJ, Li B, Lu X, Cao XT, Ling C (2009) Melittin, a major component of bee venom, sensitizes human hepatocellular carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by activating CaMKII-TAK1-JNK/p38 and inhibiting IκBα Kinase-NFκB. J Biol Chem 284:3804–3813. doi: 10.1074/jbc.m807191200 CrossRefGoogle Scholar